The association between porphyria cutanea tarda and diabetes mellitus: Analysis of a long-term follow-up cohort

British Journal of Dermatology

Volumn 165, Issue 3, 2011, Pages 486-491

  Munoz Santos C ^a   Guilabert, A ^a   Moreno, N ^d   Gimenez, M ^b   Darwich, E ^a   To Figueras, J ^c   Herrero, C ^a  

^a Department of Dermatology ^*  (Spain)

^b Endocrinology and Diabetes Unit   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHLOROQUINE; FERRITIN; GLUCOSE;

ADULT; ARTICLE; BIVARIATE ANALYSIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPERFERRITINEMIA; IMPAIRED GLUCOSE TOLERANCE; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; RETROSPECTIVE STUDIES;

EID: 79960188169     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10401.x     Document Type: Article

References (34)

1. Thunell S, Harper P,. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda-suggestions for a handling programme. Scand J Clin Lab Invest 2000; 60: 561-79. (Pubitemid 32052517)
2. Mascaro JM, Herrero C,. New reasons for an archaic treatment: phlebotomy in sporadic porphyria cutanea tarda. Arch Dermatol 2003; 139: 379-80. (Pubitemid 36330590)
3. Berman J,. Porphyrie und Zuckerkrankheit: aufsuchen der Porphyrie bei Zuckerkranken. Z Ges Inn Med 1956; 11: 186-8.
4. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, et al. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med 1979; 67: 277-86. (Pubitemid 9239524)
5. Lundvall O, Weinfeld A, Lundin P,. Iron storage in porphyria cutanea tarda. Acta Med Scand 1970; 2: 37-53.
6. Méndez M, Rossetti MV, del Cármen Batlle AM, Parera VE,. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. J Am Acad Dermatol 2005; 52: 417-24.
7. Rossmann-Ringdahl I, Olsson R,. Porphyria cutanea tarda in a Swedish population: risk factors and complications. Acta Derm Venereol (Stockh) 2005; 85: 337-41. (Pubitemid 41113517)
8. Jalil S, Grady JJ, Lee C, Anderson KE,. Associations among behavior-related susceptibility factors in porphyria cutanea tarda. Clin Gastroenterol Hepatol 2010; 8: 297-302.
9. Lamon JM, Frykholm BC,. Pregnancy and porphyria cutanea tarda. Johns Hopkins Med J 1979; 145: 235-7. (Pubitemid 10161160)
10. Kostler E,. Porphyria cutanea tarda and diabetes mellitus. Dermatol Monatsschr 1986; 172: 481-4.
11. Krivosheev AB, Kuimov AD, Krivosheeva IA,. The combination of carbohydrate and porphyrinic exchange disturbances: is it a chance or regularity? Klin Med (Mosk) 2006; 84: 51-4.
12. Muñoz-Santos C, Guilabert A, Moreno N, et al. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore) 2010; 89: 69-74.
13. Berman J, Bielicky T,. Some external factors in the etiology of porphyria cutanea tarda and diabetes mellitus with special reference to syphilitic infection and its treatment. Dermatologica 1956; 113: 78-87.
14. Rook A, Champion RH,. Porphyria cutanea tarda and diabetes. Br Med J 1960; 1 (5176): 860-1.
15. Burnham TK, Fosnaugh RP,. Porphyria, diabetes, and their relationship. A case report. Arch Dermatol 1961; 83: 717-22.
16. Naidenov E, Ivanov E, Polonov K, et al. Carbohydrate metabolic disorders in porphyria cutanea tarda. Vutr Boles 1987; 26: 62-5.
17. Lisi P, Santeusanio F, Lombardi G, Compagnucci P,. Carbohydrate metabolism in porphyria cutanea tarda. Dermatologica 1983; 166: 287-93. (Pubitemid 13065374)
18. Mengistu M,. Glucose tolerance and glycosuria in Ethiopian porphyria cutanea tarda patients. Trop Geogr Med 1987; 39: 361-5.
19. Mengistu M, Gebreselassie F, Tsega E,. Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda. Ethiop Med J 1989; 27: 107-14.
20. Franks AG Jr, Pulini M, Bickers DR, et al. Carbohydrate metabolism in porphyria cutanea tarda. Am J Med Sci 1979; 277: 163-71. (Pubitemid 9196856)
21. Bleasel NR, Varigos GA,. Porphyria cutanea tarda. Australas J Dermatol 2000; 41: 197-206.
22. Elder GH,. Porphyria cutanea tarda and related disorders. In: The Porphyrin Handbook: Medical Aspects of Porphyria (, Kadish KM, Smith KM, Guilard R, eds), Vol. 14. San Diego, CA: Academic Press, 2003; 67-92.
23. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl. 1): S11-61.
24. Masia R, Sala J, Rohlfs I, et al. Prevalence of diabetes mellitus in the province of Girona, Spain: the REGICOR study. Rev Esp Cardiol 2004; 57: 261-4. (Pubitemid 38594212)
25. Jehn ML, Guallar E, Clark JM, et al. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2007; 165: 1047-54. (Pubitemid 46598829)
26. Sun L, Franco OH, Hu FB, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2008; 93: 4690-6.
27. Jiang R, Manson JE, Meigs JB, et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004; 291: 711-17. (Pubitemid 38543791)
28. Forouhi NG, Harding AH, Allison M, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007; 50: 949-56. (Pubitemid 46559245)
29. Fumeron F, Péan F, Driss F, et al. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 2006; 29: 2090-4. (Pubitemid 44871192)
30. Brudevold R, Hole T, HammerstrÃm J,. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS ONE 2008; 3: e3547.
31. Utzschneider KM, Kowdley KV,. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 2010; 6: 26-33.
32. Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 2010; 298: E1236-43.
33. Torti FM, Torti SV,. Regulation of ferritin gene and protein. Blood 2002; 99: 3505-16.
34. Puy H, Gouya L, Deybach JC,. Porphyrias. Lancet 2010; 375: 924-37.